QT
ACRS icon

Quantbot Technologies’s Aclaris Therapeutics ACRS Stock Holding History

Quantbot Technologies’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,700
Closed -$70.4K – 1526
2023
Q1 		$70.4K Buy
+8,700
New +$110K 0.01% 1182
2021
Q4 		– Sell
-765
Closed -$13K – 1445
2021
Q3 		$13K Buy
+765
New +$12.3K ﹤0.01% 1319
2021
Q1 		– Sell
-200
Closed -$1K – 1361
2020
Q4 		$1K Buy
+200
New +$844 ﹤0.01% 1211
2018
Q1 		– Sell
-7,204
Closed -$177K – 1181
2017
Q4 		$177K Buy
7,204
+3,350
+87% +$81.6K 0.02% 726
2017
Q3 		$99K Buy
+3,854
New +$103K 0.01% 842

Other funds holding ACRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quantbot Technologies's ACRS Position: Q2 2023 in Review

Quantbot Technologies sold out of Aclaris Therapeutics (ACRS) in Q2 2023, closing a stake of 8,700 shares — an estimated $70.4K sold.

Quantbot Technologies first reported a position in ACRS in Q3 2017 and held it in 5 quarters. The position peaked at $177K in Q4 2017. 133 funds tracked by Wall St. Rank hold ACRS as of Q2 2023.

  • Quantbot Technologies reported no remaining Aclaris Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Quantbot Technologies sold 8,700 Aclaris Therapeutics shares in Q2 2023, an estimated $70.4K.
  • Quantbot Technologies first reported a position in Aclaris Therapeutics in Q3 2017 and held it in 5 quarters.
  • Quantbot Technologies's Aclaris Therapeutics position peaked at $177K in Q4 2017.
  • 133 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.